E

Elaidi, R., Harbaoui, A., Beuselinck, B., Eymard, J..-C.., Bamias, A., De Guillebon, E., Porta, C., Vano, Y., Linassier, C., Debruyne, P. R., Gross-Goupil, M., Ravaud, A., Aitelhaj, M., Marret, G. and Oudard, S. (2014) Outcomes from second-line therapy in long-term responders to first-line tyrosine kinase inhibitor in clear-cell metastatic renal cell carcinoma. Annals of Oncology, 26 (2). pp. 378-385. ISSN 0923-7534 (Print), 1569-8041 (Online) (doi:https://doi.org/10.1093/annonc/mdu552)